to me this is commercially as good as the proposed paid trial in Germany where up to 84 hospitals are on NUB list being able to negotiate costs for reimbursement during the trial , but trial is waiting for final approval by GBA to get started
if not even better
I’m sure the market will react in the next few days once UK news is digested
Ann: UK Private Insurer Approves Reimbursement for OncoSil, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.020(1.67%) |
Mkt cap ! $22.21M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.20 | $1.16 | $30.65K | 26.06K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15099 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 5000 | 1 |
View Market Depth
| Last trade - 15.59pm 18/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |